by Lee Ji-yoon
Published : Aug. 18, 2026 - 15:32:31
SK Biopharm disclosed Tuesday that it signed a drug supply contract with its subsidiary SK Life Science.
The contract is valued at 99.42 billion won ($70.3 million), equivalent to 14.1 percent of the company's 2025 sales.
The contract runs through Aug. 27.
This content was produced with the assistance of AI translation services.
Whipped while down: The dark side of horse-drawn carriages in the world's top tourist city
Aug. 27, 2026
Woman defecates on Tokyo street as police walk past
Sept. 2, 2026
Korea to crack down on cherry-picked online reviews with new disclosure rules
Sept. 7, 2026
Actor Kim Ok-bin announces pregnancy 10 months after marriage
Sept. 7, 2026
E-scooters to be banned from Seoul's Daechi-dong hagwon district starting Sept. 30
Sept. 6, 2026
